Overview

Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The goal of this research study is to evaluate the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Rivastigmine